PL362008A1 - Novel aggrecanase molecules - Google Patents

Novel aggrecanase molecules

Info

Publication number
PL362008A1
PL362008A1 PL36200801A PL36200801A PL362008A1 PL 362008 A1 PL362008 A1 PL 362008A1 PL 36200801 A PL36200801 A PL 36200801A PL 36200801 A PL36200801 A PL 36200801A PL 362008 A1 PL362008 A1 PL 362008A1
Authority
PL
Poland
Prior art keywords
novel aggrecanase
aggrecanase molecules
molecules
novel
aggrecanase
Prior art date
Application number
PL36200801A
Other languages
English (en)
Polish (pl)
Inventor
Lisa Anne Racie
Natalie Constance Twine
Michael John Agostino
Neil Michael Wolfman
Elisabeth Ann Morris
Original Assignee
Genetics Institute, Llc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute, Llc. filed Critical Genetics Institute, Llc.
Publication of PL362008A1 publication Critical patent/PL362008A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL36200801A 2000-10-20 2001-10-17 Novel aggrecanase molecules PL362008A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24231700P 2000-10-20 2000-10-20

Publications (1)

Publication Number Publication Date
PL362008A1 true PL362008A1 (en) 2004-10-18

Family

ID=22914296

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36200801A PL362008A1 (en) 2000-10-20 2001-10-17 Novel aggrecanase molecules

Country Status (13)

Country Link
EP (1) EP1326967A2 (cs)
JP (2) JP2004512043A (cs)
AU (1) AU2002245758A1 (cs)
BR (1) BR0114719A (cs)
CA (1) CA2426463A1 (cs)
CZ (1) CZ2003996A3 (cs)
MX (1) MXPA03003425A (cs)
NO (1) NO20031649L (cs)
NZ (1) NZ525368A (cs)
PL (1) PL362008A1 (cs)
SK (1) SK4632003A3 (cs)
WO (1) WO2002034895A2 (cs)
ZA (1) ZA200303865B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11261260B2 (en) 2017-06-02 2022-03-01 Merck Patent Gmbh ADAMTS binding immunoglobulins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391610B1 (en) * 1999-08-06 2002-05-21 The Cleveland Clinic Foundation Nucleic acids encoding zinc metalloproteases
AU7717800A (en) * 1999-09-27 2001-04-30 Curagen Corporation Novel polynucleotides encoding proteins containing thrombospondin type 1 repeats

Also Published As

Publication number Publication date
WO2002034895A2 (en) 2002-05-02
AU2002245758A1 (en) 2002-05-06
CZ2003996A3 (cs) 2004-04-14
BR0114719A (pt) 2004-01-27
JP2004512043A (ja) 2004-04-22
CA2426463A1 (en) 2002-05-02
NO20031649L (no) 2003-06-11
ZA200303865B (en) 2004-08-19
EP1326967A2 (en) 2003-07-16
NZ525368A (en) 2006-03-31
SK4632003A3 (en) 2004-05-04
MXPA03003425A (es) 2004-05-04
WO2002034895A3 (en) 2002-10-10
NO20031649D0 (no) 2003-04-10
JP2008301813A (ja) 2008-12-18

Similar Documents

Publication Publication Date Title
AU3662101A (en) Cd40-binding apc-activating molecules
IL150544A0 (en) Novel biarylcarboxamides
AU8860401A (en) Novel guanidinobenzamides
AU1217102A (en) Novel arylalkane-sulfonamides
ZA200406889B (en) Aggrecanase molecules
AU8197001A (en) Novel arylethene-sulfonamides
AU2002224415A1 (en) Aggrecanase molecules
EP1409658A4 (en) Aggrecanase MOLECULES
GB0022670D0 (en) Molecules
PL362008A1 (en) Novel aggrecanase molecules
GB0002625D0 (en) Dendroaspin molecules
GB0021066D0 (en) Novel process
AU2002360832A8 (en) Aggrecanase molecules
HK1056577A (en) Novel aggrecanase molecules
GB0022992D0 (en) Novel vompounds
GB0008802D0 (en) Molecule
GB0013487D0 (en) Novel process
GB0025616D0 (en) Novel process
GB0101446D0 (en) Molecules
GB0011068D0 (en) Molecules
GB0013106D0 (en) Molecules
GB0126756D0 (en) Novel molecules
GB0128776D0 (en) Novel molecules
GB0111434D0 (en) Novel molecules
HK1062028A (en) Aggrecanase molecules